Author:
Ozeke Ozcan,Cay Serkan,Ozcan Firat,Topaloglu Serkan,Aras Dursun, , , , ,
Funder
This article is published under the Creative Commons Attribution Non-commercial License.
Publisher
Touch Medical Media, Ltd.
Reference103 articles.
1. Packer DL, Mark DB, Robb RA, et al. Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation (CABANA) trial: study rationale and design. Am Heart J. 2018;199:192–9.
2. Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA randomized clinical trial. JAMA. 2019;321: 1261–74.
3. Mark DB, Anstrom KJ, Sheng S, et al. Effect of Catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: The CABANA randomized clinical trial. JAMA. 2019;321:1275–85.
4. Vergara G. #CABANA more questions than answers. Not sure it answered what it was supposed to answer. Very very muddy results. 2018. Available at: https://twitter.com/drgastonvergara/status/994960253925150721 (accessed 11 June 2019).
5. Gupta A. Five reputable sites. $4.5 billion business. Yet two completely opposite interpretations of today's #CABANA (atrial fibrillation ablation vs med) trial results. Can someone make sense of this? 2018. Available at: https://twitter.com/AtulGupta_MD/status/994710193878589442 (accessed 11 June 2019).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献